Sonnet biotherapeutics (nasdaq:sonn) participates in virtual investor "what this means" segment hosted by jtc team

Watch the "what this means" segment here frenchtown, nj / accesswire / july 24, 2024 / jtc team ("jtc"), a fully integrated corporate communications and investor relations firm, today released a virtual investor "what this means" segment featuring sonnet biotherapeutics, inc. (nasdaq:sonn), a clinical-stage company developing targeted immunotherapeutic drugs. as part of the "what this means" segment, pankaj mohan, phd, founder and chief executive officer, richard kenney, m.d.
SONN Ratings Summary
SONN Quant Ranking